AstraZeneca PLC Stock Options
| AZN Stock | USD 74.93 1.59 2.08% |
AstraZeneca PLC's latest option contracts expiring on June 20th 2025 are carrying combined implied volatility of 0.41 with a put-to-call open interest ratio of 0.2 over 45 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on June 20th 2025. The total put volume is at 89.0, with calls trading at the volume of 220. This yields a 0.4 put-to-call volume ratio.
Open Interest Against June 20th 2025 Option Contracts
2025-06-20
The chart above shows AstraZeneca PLC's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. AstraZeneca PLC's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for AstraZeneca PLC's option, there is no secondary market available for investors to trade.
AstraZeneca PLC Maximum Pain Price Across 2025-06-20 Option Contracts
Max pain occurs when AstraZeneca PLC's market makers reach a net positive position across all AstraZeneca PLC's options at a strike price where option holders stand to lose the most money. By contrast, AstraZeneca PLC's option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on AstraZeneca PLC
Analyzing AstraZeneca PLC's in-the-money options over time can help investors to take a profitable long position in AstraZeneca PLC regardless of its overall volatility. This is especially true when AstraZeneca PLC's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money AstraZeneca PLC's options could be used as guardians of the underlying stock as they move almost dollar for dollar with AstraZeneca PLC's stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on AstraZeneca PLC lessens the impact of time decay, as they carry both intrinsic and time value. So, even if AstraZeneca PLC's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money AstraZeneca PLC contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if AstraZeneca Stock moves the wrong way.
AstraZeneca PLC ADR In The Money Call Balance
When AstraZeneca PLC's strike price is surpassing the current stock price, the option contract against AstraZeneca PLC ADR stock is said to be in the money. When it comes to buying AstraZeneca PLC's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on AstraZeneca PLC ADR are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
AstraZeneca Current Options Market Mood
AstraZeneca PLC's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps AstraZeneca Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of AstraZeneca PLC's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. AstraZeneca PLC's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current AstraZeneca contract
Base on the Rule 16, the options market is currently suggesting that AstraZeneca PLC ADR will have an average daily up or down price movement of about 0.0256% per day over the life of the 2025-06-20 option contract. With AstraZeneca PLC trading at USD 74.93, that is roughly USD 0.0192. If you think that the market is fully incorporating AstraZeneca PLC's daily price movement you should consider buying AstraZeneca PLC ADR options at the current volatility level of 0.41%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
AstraZeneca |
Purchasing AstraZeneca PLC options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" AstraZeneca calls. Remember, the seller must deliver AstraZeneca PLC ADR stock to the call owner when a call is exercised.
AstraZeneca PLC Option Chain
When AstraZeneca PLC's strike price is surpassing the current stock price, the option contract against AstraZeneca PLC ADR stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
AstraZeneca PLC's option chain is a display of a range of information that helps investors for ways to trade options on AstraZeneca. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for AstraZeneca. It also shows strike prices and maturity days for a AstraZeneca PLC against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | AZN250620C00110000 | 74 | 110.0 | 0.0 - 2.15 | 0.05 | Out |
Call | AZN250620C00105000 | 1 | 105.0 | 0.0 - 2.16 | 0.1 | Out |
Call | AZN250620C00100000 | 42 | 100.0 | 0.0 - 1.39 | 0.21 | Out |
Call | AZN250620C00095000 | 204 | 95.0 | 0.03 - 2.23 | 0.3 | Out |
Call | AZN250620C00090000 | 192 | 90.0 | 0.23 - 1.31 | 0.5 | Out |
Call | AZN250620C00087500 | 110 | 87.5 | 0.4 - 2.02 | 0.69 | Out |
Call | AZN250620C00085000 | 984 | 85.0 | 0.67 - 0.84 | 0.74 | Out |
Call | AZN250620C00082500 | 602 | 82.5 | 1.11 - 1.23 | 1.19 | Out |
Call | AZN250620C00080000 | 6676 | 80.0 | 1.78 - 1.93 | 1.85 | Out |
Call | AZN250620C00077500 | 13763 | 77.5 | 2.72 - 2.79 | 2.79 | Out |
Call | AZN250620C00075000 | 6172 | 75.0 | 3.9 - 4.05 | 4.15 | Out |
Call | AZN250620C00072500 | 1978 | 72.5 | 5.4 - 5.7 | 5.5 | In |
Call | AZN250620C00070000 | 10667 | 70.0 | 7.1 - 7.55 | 7.25 | In |
Call | AZN250620C00067500 | 2917 | 67.5 | 9.05 - 9.95 | 9.77 | In |
Call | AZN250620C00065000 | 426 | 65.0 | 11.25 - 11.45 | 11.79 | In |
Call | AZN250620C00062500 | 139 | 62.5 | 13.45 - 13.7 | 16.85 | In |
Call | AZN250620C00060000 | 351 | 60.0 | 15.75 - 16.05 | 16.93 | In |
Call | AZN250620C00057500 | 88 | 57.5 | 18.15 - 18.85 | 12.34 | In |
Call | AZN250620C00055000 | 15 | 55.0 | 18.75 - 20.85 | 15.35 | In |
Call | AZN250620C00050000 | 8 | 50.0 | 25.4 - 26.65 | 27.38 | In |
Put | AZN250620P00110000 | 0 | 110.0 | 34.05 - 35.55 | 34.05 | In |
Put | AZN250620P00105000 | 0 | 105.0 | 29.0 - 30.9 | 36.25 | In |
Put | AZN250620P00100000 | 0 | 100.0 | 23.65 - 25.4 | 28.65 | In |
Put | AZN250620P00095000 | 0 | 95.0 | 18.2 - 21.2 | 21.8 | In |
Put | AZN250620P00090000 | 0 | 90.0 | 14.2 - 15.95 | 15.75 | In |
Put | AZN250620P00087500 | 47 | 87.5 | 11.85 - 12.8 | 20.2 | In |
Put | AZN250620P00085000 | 9 | 85.0 | 9.55 - 10.3 | 8.85 | In |
Put | AZN250620P00082500 | 164 | 82.5 | 6.45 - 8.15 | 7.14 | In |
Put | AZN250620P00080000 | 482 | 80.0 | 6.05 - 6.25 | 5.15 | In |
Put | AZN250620P00077500 | 672 | 77.5 | 4.45 - 4.6 | 4.25 | In |
Put | AZN250620P00075000 | 1761 | 75.0 | 3.2 - 3.3 | 3.2 | Out |
Put | AZN250620P00072500 | 477 | 72.5 | 2.19 - 2.31 | 2.01 | Out |
Put | AZN250620P00070000 | 1698 | 70.0 | 1.44 - 1.6 | 1.47 | Out |
Put | AZN250620P00067500 | 451 | 67.5 | 0.91 - 1.08 | 0.89 | Out |
Put | AZN250620P00065000 | 1311 | 65.0 | 0.56 - 2.09 | 0.62 | Out |
Put | AZN250620P00062500 | 1197 | 62.5 | 0.39 - 0.44 | 0.53 | Out |
Put | AZN250620P00060000 | 320 | 60.0 | 0.11 - 1.27 | 0.3 | Out |
Put | AZN250620P00057500 | 170 | 57.5 | 0.07 - 2.31 | 0.69 | Out |
Put | AZN250620P00055000 | 58 | 55.0 | 0.1 - 2.26 | 0.13 | Out |
Put | AZN250620P00050000 | 11 | 50.0 | 0.0 - 2.2 | 0.09 | Out |
Put | AZN250620P00047500 | 4 | 47.5 | 0.0 - 2.19 | 0.04 | Out |
Put | AZN250620P00045000 | 3 | 45.0 | 0.0 - 2.17 | 0.03 | Out |
Put | AZN250620P00042500 | 15 | 42.5 | 0.0 - 2.16 | 0.08 | Out |
Put | AZN250620P00040000 | 6 | 40.0 | 0.0 - 1.32 | 0.01 | Out |
Put | AZN250620P00037500 | 19 | 37.5 | 0.0 - 1.31 | 0.02 | Out |
AstraZeneca PLC Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
AstraZeneca PLC Market Cap Over Time
Market Cap |
| Timeline |
AstraZeneca Total Stockholder Equity
Total Stockholder Equity |
|
AstraZeneca PLC Corporate Directors
| Marc Dunoyer | Chief Financial Officer, Executive Director | Profile | |
| Sherilyn McCoy | Non-Executive Independent Director | Profile | |
| Genevieve Berger | Non-Executive Independent Director | Profile | |
| Nazneen Rahman | Non-Executive Independent Director | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AstraZeneca PLC ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AstraZeneca PLC. If investors know AstraZeneca will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AstraZeneca PLC listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.567 | Dividend Share 3.1 | Earnings Share 2.25 | Revenue Per Share | Quarterly Revenue Growth 0.238 |
The market value of AstraZeneca PLC ADR is measured differently than its book value, which is the value of AstraZeneca that is recorded on the company's balance sheet. Investors also form their own opinion of AstraZeneca PLC's value that differs from its market value or its book value, called intrinsic value, which is AstraZeneca PLC's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AstraZeneca PLC's market value can be influenced by many factors that don't directly affect AstraZeneca PLC's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AstraZeneca PLC's value and its price as these two are different measures arrived at by different means. Investors typically determine if AstraZeneca PLC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AstraZeneca PLC's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.